National Health Investors (NHI) FY2015 results: revenue $229 million, up 29.0% on the year
National Health Investors Inc. (NHI) reported revenue of $229 million for fiscal 2015, the year ended 31 December 2015, up 29.0% on the year before. Net income was $149 million, up 46.5%, and diluted earnings per share $3.95. The figures are the company's own, from the 10-K it filed with the SEC on 18 February 2016.
Revenue
$229 million
+29.0% on the year
FY2008FY2015
Operating margin
65.6%
58.1% a year earlier
FY2008FY2015
Net income
$149 million
+46.5% on the year
FY2008FY2015
Diluted EPS
$3.95
+29.9% on the year
FY2008FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
229
178
118
+29.0%
Operating income
150
103
79.5
+45.9%
Operating margin
65.6%
58.1%
67.5%
Interest expense
37.6
26.4
9.2
+42.7%
Pre-tax income
127
103
75.9
+22.9%
Income tax
-0.6
0.1
0.1
Effective tax rate
-0.5%
0.1%
0.2%
Net income
149
102
106
+46.5%
Net margin
65.0%
57.2%
90.1%
Diluted EPS
$3.95
$3.04
$3.74
+29.9%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
164
126
104
+30.3%
Capital expenditure
124
533
655
-76.7%
Free cash flow
40.3
-407
-550
Free cash flow margin
17.6%
-229.3%
-467.2%
Cash from investing
-136
-540
-626
Cash from financing
-18.1
406
524
Share-based compensation
2.1
2.0
2.3
+5.6%
Dividends paid
125
101
85.1
+23.9%
Dividend per share
$3.40
$3.08
$2.90
+10.4%
Diluted shares, weighted
38m
33m
28m
+12.7%
Shares outstanding at period end
38m
37m
33m
+2.4%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
1,133
1,040
767
+9.0%
Non-controlling interest
9.2
10.0
10.6
-8.4%
Debt
914
863
617
+6.0%
Other liabilities
76.3
70.3
61.6
+8.6%
Total liabilities and equity
2,133
1,983
1,456
+7.6%
Fixed assets
1,837
1,777
1,248
+3.4%
Loans
134
63.6
60.6
+110.1%
Cash and equivalents
13.1
3.1
11.3
+323.5%
Receivables
3.3
3.8
2.5
-14.7%
Other assets
146
136
134
+7.7%
Total assets
2,133
1,983
1,456
+7.6%
10-K for the year ended 31 December 2015, filed 18 February 2016: the filing.